PatientPay Partners with Azalea Health to Streamline Billing for Ambulatory Providers

Share This Post

Key Highlights

  • PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.
  • Faster revenue capture with less than 14 days to payment, far below industry averages.
  • 48.8% of electronic billing messages convert to payments, improving financial outcomes for rural healthcare.
  • Partnership supports community hospitals with higher bill conversion rates and lower A/R days.

Source: Business Wire

Notable Quotes

  • “Our new partnership will assist their clients to move the needle on the overall financial health so they can continue delivering vital care  to their communities.” — Tom Furr, CEO at PatientPay
  • “PatientPay is a welcome addition to our network and this partnership is a testament to our commitment to offer our customers innovative, integrated solutions to drive profitability and sustainability.”  Baha Zeidan, CEO at Azalea Health

SoHC's Take

This partnership between PatientPay and Azalea Health is a strategic move that addresses the critical financial challenges faced by rural and community-based healthcare providers. By leveraging Azalea Health’s API infrastructure, PatientPay accelerates the billing process, which is crucial for organizations operating on narrow margins. This collaboration not only improves cash flow but also enhances patient satisfaction by simplifying payment processes, a much-needed advancement in the healthcare financial landscape.

Heading

Key Highlights Vijay Parthasarathy, Ph.D., MBA, joins Sunbird Bio as chief product and strategy officer.Will lead the strategic launch of Sunbird Bio’s ...
/
Key Highlights Robert J. Hombach joins Seaport Therapeutics’ Board of Directors and will chair the Audit Committee.Brings three decades of financial and operational leadership in healthcare.Former EVP, ...
/
Key Highlights Preet Takkar named Chief Executive Officer and Board Member of Sonrava Health.Brings over 25 years of experience in ...
/
Key Highlights Renée Galá appointed to Dexcom’s Board of Directors, effective March 6, 2025.Brings extensive financial, strategic, and operational leadership ...
/
Key Highlights Abbas Kazimi appointed as CEO and Board Member of Nimbus Therapeutics, effective immediately.Succeeds Jeb Keiper, MS, MBA, following a ...
/
Key Highlights Dr. Michael L. Parks named second vice president of AAOS BOD.Will serve as AAOS president in 2027.Brings extensive ...
/

More To Explore

Total
0
Share